Skip to main content
NIH funding notice PAR-19-235

Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)

Closed on May 7, 2022.

Posted
April 2, 2019
Close date
May 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $233,250 in first-year total cost, median $233,250.

Most frequent study sections

  1. Mental Health Services Study Section[SERV]1

Most frequent institutions

  1. UNIVERSITY OF WASHINGTON1
Competing awards under PAR-19-235 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Development and testing of a caregiver-facing mobile health intervention to reduce duration of untreated psychosis1R34MH124878-01A1BUCK, BENJAMIN EDWARDSUNIVERSITY OF WASHINGTON, WA$233,250SERV

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.